U.S. market Closed. Opens in 12 hours

PPBT | Purple Biotech Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
RevenueN/A-910.00K-320.00K1.00M1.00M1.00MN/AN/AN/AN/AN/A
Cost of Revenue199.00K201.00K231.00K235.00K80.00N/AN/AN/AN/AN/AN/A
Gross Profit-199.00K-1.11M-551.00K765.00K999.92K1.00MN/AN/AN/AN/AN/A
Operating Expenses22.07M22.60M17.93M13.79M8.75M8.83M11.03MN/AN/AN/AN/A
Selling, General & Admin5.04M6.28M6.11M6.31M6.08M4.45M6.39M3.00M1.51M1.27M1.06M
Research & Development17.03M16.32M11.83M7.49M2.67M5.27M4.64M4.18M2.56M3.19M109.00K
Other Operating ExpensesN/AN/AN/A-15.65M-216.00KN/AN/AN/AN/AN/AN/A
Operating Income-22.27M-22.60M-17.93M12.61M-7.16M-7.83M-12.06M-7.18M-4.07M-5.18M-1.17M
Other Expenses / Income2.29M843.00K108.00K-40.69M1.26M2.74M-947.00K-4.94M-133.00K-71.00K-1.46M
Before Tax Income-19.98M-21.76M-17.83M-28.07M-5.89M-5.57M-13.01M-12.12M-4.20M-5.25M-2.63M
Income Tax Expenses-97.00K-935.00K637.00K-15.67M216.00K-2.63MN/AN/AN/AN/AN/A
Net Income-19.88M-20.82M-18.46M-12.40M-6.11M-5.20M-12.27M-12.12M-4.20M-5.25M-2.63M
Interest Expenses2.18M126.00K212.00K61.00K181.00K576.00K26.00K6.00K3.00K21.00K48.00K
Basic Shares Outstanding24.62M18.48M17.80M17.21M1.94M19.54M945.70K575.58K96.25K380.68K380.68K
Diluted Shares Outstanding24.62M18.48M17.80M17.21M1.94M19.54M945.70K575.58K96.25K380.68K380.68K
EBITDA-22.07M-21.43M-17.38M-27.96M-7.64M-7.73M-12.24M-7.10M-4.20M-5.23M-1.20M
EBITDA Margin0.00%2,355.27%5,432.19%-2,796.00%-763.80%-772.60%0.00%0.00%0.00%0.00%0.00%
EBIT-17.80M-21.63M-17.61M-28.01M-5.71M-7.25M-12.25M-12.12M-4.20M-5.23M-2.58M
EBIT Margin0.00%2,377.36%5,504.38%-2,801.30%-571.20%-725.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙